Invezz

Alcon (ALC)

NYSE Market Open

Alcon Inc. is a global eye care company serving both the vision care and ophthalmic surgery markets. Formerly part of Novartis, it became an independent public company in 2019 and now operates as one of the most recognizable names in products used to correct, protect, and improve eyesight. Its business is built around long-term demand for eye health solutions driven by ageing populations, rising rates of myopia, and continued innovation in surgical and contact lens technologies.

The vision care segment includes daily and reusable contact lenses, lens care solutions, and ocular health products. Alcon’s contact lens brands include Dailies, Total1, and Air Optix, which compete across premium and mass-market categories. The company also sells products aimed at dry eye relief, allergy care, and general eye wellness, giving it a broad presence in optometry and retail channels.

Alcon’s surgical segment supplies equipment, implantable lenses, and consumables used by ophthalmologists. Its portfolio includes phacoemulsification systems for cataract surgery, such as Centurion, along with intraocular lenses including PanOptix and Vivity. These products support procedures that restore or improve vision, particularly cataract operations, one of the most common surgical categories worldwide.

A key strength of Alcon is its large installed base of surgical equipment, which can create recurring demand for consumables, service, and related products. The company competes in markets where brand trust, clinical performance, surgeon familiarity, and regulatory approvals matter. Its position combines consumer-facing vision products with specialized medical technology used in operating rooms.

65.96 USD
+1.75 (+2.73%)

Last updated

Market Cap
31.32B
P/E
71.18
P/FCF
P/S
3.65
Enterprise Value
34.26B
Sector
Industry
Address
GlobeNewswire Inc.

National Advertising Division Finds Certain ACUVUE® Oasys Max Claim Supported; Recommends Modification or Discontinuation of Others

Apr 20, 2026, 10:48 AM
GlobeNewswire Inc.

2026 DallasCISO ORBIE Awards Recognize Top Security Executives

Feb 26, 2026, 13:36 PM
GlobeNewswire Inc.

LENSAR® Provides Update on Pending Acquisition by Alcon

Feb 25, 2026, 17:00 PM
GlobeNewswire Inc.

Contact Lens Market Size to Hit USD 26.64 Billion by 2033, Driven by Rising Vision Care Awareness and Technological Advancements – SNS Insider

Jan 16, 2026, 07:00 AM
GlobeNewswire Inc.

Ophthalmic Drugs Market Size to Cross USD 62.74 Billion by 2032, Driven by Advances in Eye Care Treatments and Rising Global Vision Disorders - SNS Insider

Dec 07, 2025, 08:05 AM
GlobeNewswire Inc.

Global Surgical Microscopes Market to Surpass USD 2.59 Billion by 2030 | MarketsandMarkets™

Nov 21, 2025, 09:00 AM
GlobeNewswire Inc.

Global Cataract Surgery Devices Market to Grow at a CAGR of ~5% Driven by Innovation and Increasing Patient Awareness | DelveInsight

Oct 21, 2025, 13:00 PM
GlobeNewswire Inc.

LENSAR Reports Second Quarter 2025 Results and Provides Business Update

Aug 07, 2025, 07:00 AM
GlobeNewswire Inc.

Gordon Schanzlin New Vision Institute First in Region to Offer Groundbreaking Alcon Sitemap Technology for Personalized Vision Correction

May 28, 2025, 13:00 PM
GlobeNewswire Inc.

U.S. Ophthalmic Photocoagulator Growth Trends and Forecasts 2025-2032 - Market Expands Amid Surge in Diabetic Retinopathy Cases

May 26, 2025, 10:56 AM
GlobeNewswire Inc.

Global Intraocular Lens Market to Witness Upsurge in Growth at a CAGR of ~5% by 2032 | DelveInsight

May 15, 2025, 13:00 PM
GlobeNewswire Inc.

Ophthalmic Devices Market Set to Attain Valuation of US$ 83.33 Billion By 2033 | Astute Analytica

Apr 08, 2025, 13:30 PM
GlobeNewswire Inc.

Ophthalmology Market Report 2025 | Industry to Reach US$93.7 Billion by 2030 | Emerging Research Activities of Ophthalmology Treatments and Availability of Grants Present Business Opportunities

Apr 08, 2025, 04:52 AM
GlobeNewswire Inc.

Ophthalmic Drugs Global Market Report 2025: Innovations in Retinal Disorders, Glaucoma Drive Global Ophthalmic Medicines Surge

Jan 13, 2025, 04:46 AM
GlobeNewswire Inc.

Diabetic Retinopathy Global Clinical Trials Review 2024: Region, country (G7 & E7), phase, trial status, End-points Status and Sponsor Type

Jan 10, 2025, 09:35 AM
GlobeNewswire Inc.

Ophthalmic Lasers Market Forecast Report to 2029: Key Trends Include Growing Popularity of Femtosecond Lasers in Ophthalmic Surgery and Growing Preference for Minimally Invasive Ophthalmic Procedures

Jan 06, 2025, 09:44 AM
GlobeNewswire Inc.

Ocular Prosthesis Market Trends, Challenges and Opportunities to 2030: A Projected $2.3 Billion Landscape

Dec 24, 2024, 05:57 AM
GlobeNewswire Inc.

Aesthetic Ophthalmology Devices Business Analysis Report 2024-2030 Featuring 40+ Key Players Including Abbott, Bausch & Lomb, Alcon, Allergan, Carl Zeiss, Haag Streit, Meditec, Topcon, Zeimer

Dec 23, 2024, 10:59 AM
GlobeNewswire Inc.

Ophthalmic Lasers Market, Competitive Landscape and Market Forecasts to 2030

Dec 16, 2024, 11:52 AM
GlobeNewswire Inc.

Ophthalmology Devices Market Analysis Report 2025-2030: Industry Trends, Market Shares and Competitive Strategies

Nov 21, 2024, 04:57 AM
Market Cap
31.32B
Enterprise Value
34.26B
P/E
71.18
P/B
1.6
P/S
3.65
EV / EBITDA
32.2
EV / Sales
3.99
EPS
0.9
Dividend Yield
0%
P/FCF
P/CF
Free Cash Flow
ROE
2.25%
ROA
1.59%
Debt / Equity
0.2
Current Ratio
2.16
Quick Ratio
1.31
Cash
0.44
Avg Volume
2.43M
Fundamentals Snapshot Price
64.22

Income Statement

Line Item 2025 Q4 2024 Q4 2023 Q4 2022 Q4 2022 Q2
Revenue 2.22B
Gross profit 1.2B
Operating income 200M
EBITDA 0 0 0 0 200M
Net income 148M
Basic EPS 0.3
Diluted EPS 0.3

Balance Sheet

Line Item 2025 Q4 2024 Q4 2023 Q4 2022 Q4 2022 Q2
Total assets 31.56B 30.35B 29.61B 29.17B 27.73B
Total liabilities 9.52B 8.79B 8.99B 9.49B 8.19B
Total equity 22.04B 21.55B 20.62B 19.68B 19.54B
Cash & equivalents 1.53B 1.68B 1.09B 980M 1.03B
Current assets 6.37B 6.16B 5.65B 5.19B 5.02B
Current liabilities 3.05B 2.28B 2.4B 2.74B 2.32B

Cash Flow

Line Item 2025 Q4 2024 Q4 2023 Q4 2022 Q4 2022 Q2
Operating cash flow
Investing cash flow
Financing cash flow
Change in cash
Kind Filing Date Link
edgar index SD — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index 144 — ALCON INC View Filing
edgar index 144 — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index 20-F — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index DFAN14A — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index DFAN14A — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index DEFM14A — ALCON INC View Filing
edgar index SD — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index SCHEDULE 13G/A — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index DFAN14A — ALCON INC View Filing
edgar index 144 — ALCON INC View Filing
edgar index 144 — ALCON INC View Filing
edgar index 144 — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index 20-F — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index 144 — ALCON INC View Filing
edgar index 144 — ALCON INC View Filing
edgar index 144 — ALCON INC View Filing
edgar index 144 — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index 144 — ALCON INC View Filing
edgar index 144 — ALCON INC View Filing
edgar index SD — ALCON INC View Filing
edgar index 144 — ALCON INC View Filing
edgar index 144 — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index 144 — ALCON INC View Filing
edgar index 144 — ALCON INC View Filing
edgar index 144 — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index 20-F — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index SC 13G — ALCON INC View Filing
edgar index SC 13G/A — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index 144 — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index SD — ALCON INC View Filing
edgar index 144 — ALCON INC View Filing
edgar index 144 — ALCON INC View Filing
edgar index 144 — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index 20-F — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index IRANNOTICE — ALCON INC View Filing
edgar index SC 13G — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index SC 13G/A — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index SC 13G — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index DEFA14A — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index SD — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index 6-K — ALCON INC View Filing
edgar index 20-F — ALCON INC View Filing